Citation Impact
Citing Papers
Myofascial Trigger Points Then and Now: A Historical and Scientific Perspective
2015 Standout
Primary pyomyositis caused by ca-MRSA
2008
The value of synovial fluid assays in the diagnosis of joint disease: a literature survey
2002
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
2006 Standout
Practice parameter for the diagnosis and management of primary immunodeficiency
2005
Changes Over Time in the Diagnosis of Rheumatoid Arthritis in a 10-year Cohort
2009
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
2009 Standout
Bacterial pyomyositis in the United States
2004
Lymphedema: Etiopathogenesis
1992
Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study
2006
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT)
2006 Standout
The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.
1998 Standout
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
2020 Standout
Lupus nephritis in childhood and adolescence
1994
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
Treatment of small vessel primary CNS vasculitis in children: an open-label cohort study
2010
Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment
2008
Reliability of Physical Examination for Diagnosis of Myofascial Trigger Points
2008 Standout
Rheumatoid arthritis
2010 Standout
Renal-Limited “Lupus-Like” Nephritis: How Much of a Lupus
2017 Standout
Accelerated atherosclerosis: An extraarticular feature of rheumatoid arthritis?
2002
Adaptación cultural y validación de cuestionarios de salud: revisión y recomendaciones metodológicas
2013 Standout
Sensitivity and specificity of the American College of Rheumatology 1987 criteria for the diagnosis of rheumatoid arthritis according to disease duration: a systematic literature review and meta-analysis
2008
Treatment of Erythema Migrans in Pregnancy
1996
Suppression of fever and the acute-phase response in a patient with juvenile chronic arthritis treated with monoclonal antibody to tumour necrosis factor-alpha (cA2)
1997
Microbiota Modulation of the Gut-Lung Axis in COVID-19
2021 Standout
Musculoskeletal involvement in scleroderma
2003
Gadolinium – a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?
2006 Standout
Lyme borreliosis
2011 Standout
Case 35-2004
2004
Clinical Implication of Latent Myofascial Trigger Point
2013
GENETIC CONTROL OF SUSCEPTIBILITY IN CLINICAL AND EXPERIMENTAL UVEITIS
2002
Cutaneous manifestations associated with antiphospholipid antibodies
2004
Investigation of the relationship between the onset of arthritis and uveitis in genetically predisposed SKG mice
2015 StandoutNobel
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Manual therapies in myofascial trigger point treatment: a systematic review
2004
Primary and Secondary Central Nervous System Vasculitis
2012
Hyperplasia of Lymphatic Vessels in VEGF-C Transgenic Mice
1997 StandoutScience
Guidelines for the Primary Prevention of Stroke
2014 Standout
The effectiveness of non-invasive treatments for active myofascial trigger point pain: A systematic review of the literature
2006
The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America
2006 Standout
The Overdiagnosis of Lyme Disease in Children Residing in an Endemic Area
1994
2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infectionsa
2012 Standout
Following the Molecular Pathways toward an Understanding of the Pathogenesis of Systemic Sclerosis
2004 Standout
Clinical Practice Guideline (Update): Adult Sinusitis
2015 Standout
The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation
2002
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
The prevalence of rheumatoid arthritis in Sweden
1999
Works of Barbara E. Ostrov being referenced
Clinical Assessment of the 1987 American College of Rheumatology Criteria for Rheumatoid Arthritis
1996
Lyme Disease: Difficulties in Diagnosis and Management
1991
Autoimmune manifestations of the wiskott-aldrich syndrome
1998
Myofascial Pain Unresponsive to Standard Treatment: Successful Use of a Strain and Counterstrain Technique with Physical Therapy
2000
Isolated angiitis of CNS: Treatment with pulse cyclophosphamide
1993
Pyomyositis: Report of Three Patients and Review of the Literature
1996
Clinical images: Hip joint remodeling in systemic-onset juvenile rheumatoid arthritis
2000
Vasculitis associated with antiphospholipid syndrome
1995
Hypertension in children with systemic lupus erythematosus
1989
Lymphedema associated with juvenile rheumatoid arthritis.
1989
The Impact of the Microbiome on Immunosenescence
2018
Nutrition and pediatric rheumatic diseases. Hypothesis: cytokines modulate nutritional abnormalities in rheumatic diseases.
1992
Knee contractures as the presenting manifestation of scleroderma.
1992
Increased Risk for Fetal Loss in Carriers of the Factor V Leiden Mutation
1999
Beneficial effect of etanercept on rheumatoid lymphedema
2001